Evidence map›Paper›PMID 36838040›Full record

ArticleMicromachines2023

Visible-Range Multiple-Channel Metal-Shell Rod-Shaped Narrowband Plasmonic Metamaterial Absorber for Refractive Index and Temperature Sensing.

Chung-Ting Chou Chao, Muhammad Raziq Rahimi Kooh, Chee Ming Lim, Roshan Thotagamuge, Abdul Hanif Mahadi, Yuan-Fong Chou Chau

Abstract read
In one paragraph

Article in Micromachines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Hybrid Ag nanocone-AlDiscover nano · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chung-Ting Chou ChaoDepartment of Optoelectronics and Materials Technology, National Taiwan Ocean University, Keelung 20224, Taiwan.
Muhammad Raziq Rahimi KoohCentre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Tungku Link, Gadong BE1410, Brunei.ORCID 0000-0001-7974-3162
Chee Ming LimCentre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Tungku Link, Gadong BE1410, Brunei.
Roshan ThotagamugeDepartment of Nano Science Technology, Faculty of Technology, Wayamba University of Sri Lanka, Kuliyapitiya 60200, Sri Lanka.ORCID 0000-0002-7931-199X
Abdul Hanif MahadiCentre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Tungku Link, Gadong BE1410, Brunei.ORCID 0000-0003-4121-0920
Yuan-Fong Chou ChauCentre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Tungku Link, Gadong BE1410, Brunei.ORCID 0000-0002-5249-8715

Funding

Universiti Brunei Darussalam UBD/RSCH/1.9/FICBF(b)/2022/018
6 · The paper itself

Abstract

Multiple resonance modes in an optical absorber are necessary for nanophotonic devices and encounter a challenge in the visible range. This article designs a multiple-channel plasmonic metamaterial absorber (PMA) that comprises a hexagonal arrangement of metal-shell nanorods in a unit cell over a continuous thin metal layer, operating in the visible range of the sensitive refractive index (RI) and temperature applications. Finite element method simulations are utilized to investigate the physical natures, such as the absorptance spectrum, magnetic flux and surface charge densities, electric field intensity, and electromagnetic power loss density. The advantage of the proposed PMA is that it can tune either three or five absorptance channels with a narrowband in the visible range. The recorded sensitivity and figure of merit (

Indexed as

multiple resonance modesplasmonic metamaterial absorbertemperature sensitivityvisible range

Identifiers

PMID36838040
PMCPMC9965369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.